Clinical Trial Update: Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy [NA]

View source ↗

Summary

This entry notes the completion of a clinical trial comparing intravitreal ranibizumab to sham injection before vitrectomy in patients with proliferative diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Proliferative Diabetic Retinopathy | NA | Status: COMPLETED